3 sites and 20,000 m2 of laboratories

Carbios, a pioneer in the development of enzymatic solutions dedicated to the end-of-life of plastic and textile polymers, has received alongside two significant partners T.EN Zimmer GmbH and Deloitte € 3.3 million - including € 3 million for Carbios – in the form of a European grant. 

TOTUM.070 is an innovative active substance based on a combination of 5 plant extracts, designed to reduce LDL cholesterol, a cardiovascular risk factor and the primary cause of atherosclerosis. It is developed for people with mild to moderate, untreated hypercholesterolemia.

Pascal Mayer, now head of the Alphanosos company he created in 2014 on the Riom site of the Biopôle Clermont-Limagne, has just received the Breakthrough Prize in the life sciences category, for its co-discovery of a technology developed nearly 25 years ago that revolutionized DNA analysis.

Valbiotis has obtained a patent in China for TOTUM-63. This patent protects is issued by the China National Intellectual Property Administration (CNIPA), and protects the composition and use of TOTUM-63 for the prevention of type 2 diabetes and metabolic diseases until 2035.

Michelin has successfully validated the use of Carbios’ enzymatic recycling technology for PET plastic waste in its tires, a new step towards 100% sustainable tires.

Over the past 25 years, the Icare Group, an expert in contamination control at the service of industrial health, has meshed the entire French territory and gained an international standing. Today, it invests more than 2 million euros on the Biopôle Clermont-Limagne in Saint-Beauzire to provide its headquarters with an additional 1,300 m2, an extension that allows it to strengthen its development strategy.

METabolic EXplorer has entered into negotiations with Ajinomoto Co., Inc. with a view to acquiring its European subsidiary Ajinomoto Animal Nutrition Europe (AANE), Europe’s top producer of amino acids by fermentation for animal nutrition. 

After producing the first batches of glycolic acid of natural origin with its industrial demonstrator, METEX is implementing its industrial plan for the production with its own facilities of the first bio-based glycolic acid, supported by the French government with a subsidy of nearly €10 million as part as its stimulus plan for strategic activities.

Alphanosos is a French Green-Health DeepTech company, specialized in the research of new innovative treatments. The company has developed proprietary artificial intelligence to elaborate, from aqueous botanical extracts, highly effective products against viruses, bacteria or cancer cells. This innovative approach tackles the most resistant pathologies thanks to its active ingredients, capable of unbalancing and eliminating the pathogenic target without impairing the host.